ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Genomic-Derived Markers for Early Detection of Calcineurin Inhibitor Toxicity Post-Kidney Transplantation: Contribution to Chronic Allograft Dysfunction Progression

V. Mas, J. Suh, R. Gehrau, A. King, K. Brayman, J. Lee, D. Maluf

UVA, Charlottesville
VCU, Richmond

Meeting: 2013 American Transplant Congress

Abstract number: 13

Related Abstracts
  • miRNA in Urinary Pellet Samples of Kidney Transplant Recipients as Diagnostic and Predictive Markers of Progression to Chronic Allograft Dysfunction
  • Dynamic Composite Analyses Identify Biomarkers of Progression to Chronic Allograft Dysfunction after Kidney Transplantation

Background. Use of calcineurin inhibitors (CNIs) after kidney transplantation (KT) induces vasoconstriction of renal afferent arterioles, leading to functional changes and potentially irreversible chronic ischemic structural damage. Because CNI toxicity (CNIT) might contribute to interstitial fibrosis (IF) and tubular atrophy (TA), better tests are needed to diagnose early CNIT.

Samples and Methods. 164 biopsies from 127 primary, deceased donor KT recipients (KTRs) undergoing CNI-based immunosuppression were evaluated. CNI-related nephrotoxicity was defined by histological findings compatible with CNIT (in absence of acute rejection (AR) and/or IF/TA) and rise in serum creatinine. To identify specific molecular markers of CNIT, gene expression profiling was performed in biopsies with CNIT (n=12), ACR (n=9), chronic allograft dysfunction (CAD) with IF/TA (n=10) and normal allografts (NA, n=19) (training set). An independent set of biopsies (CNIT=20; NA=20) was used as validation set for the top 15 genes (FDR≤5%). Furthermore, an independent set of paired biopsies from 37 KTRs propspectively collected at 3 and 9 months post-KT (n=74 biopsies) were evaluated to identify the contribution of CNIT in the development of CAD. Validation group patients were classified based on 2-year post-KT graft function (defined as KTRs with eGFR ≤40 ml/min/1.72cm2 and histological evidence of IF/TA (poor function group: PFG) or KTRs with continuous eGFR >40 from KT and normal histology (normal function group: NFG)).

Results. 270 probesets were differentially expressed between CNIT and NA biopsies with 55 genes being unique for CNIT. CNIT-associated molecular functions identified included cellular movement, cellular growth and proliferation and cell death (p<0.001). Molecular processes identified suggest induction of epidermal-to-mesenchymal transition during CNIT. When evaluating the contribution of CNIT to IF/TA development, PFG patients classified as showed an overlap of 20% and 40% of the CNIT signature at 3 and 9-months respectively, while 6% and 3% at 3 and 9 months on NFG patients. Moreover, 19 of these genes were identified as related to renal toxicity and further validated using QPCR.

Conclusions. We have identified a molecular signature that characterizes CNIT samples. Moreover, at the molecular level, CNIT plays a critical role as non-immunological factor in the development of CAD.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Mas V, Suh J, Gehrau R, King A, Brayman K, Lee J, Maluf D. Genomic-Derived Markers for Early Detection of Calcineurin Inhibitor Toxicity Post-Kidney Transplantation: Contribution to Chronic Allograft Dysfunction Progression [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/genomic-derived-markers-for-early-detection-of-calcineurin-inhibitor-toxicity-post-kidney-transplantation-contribution-to-chronic-allograft-dysfunction-progression/. Accessed January 17, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.